Finance

Lists
300147:SHE
Xiangxue Pharmaceutical Co Ltd
CNÂ¥6.46
+1.57%
(+0.100) 1D
Sep 8, 3:04:55 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300147...
Open
CNÂ¥6.36
High
CNÂ¥6.51
Low
CNÂ¥6.30
Mkt. cap
4.34B
Avg. vol.
10.14M
Volume
8.10M
52-wk high
CNÂ¥11.84
52-wk low
CNÂ¥5.90
EPS
-CNÂ¥2.16
Shares outstanding
661.28M
No. of employees
3K
Open
CNÂ¥6.36
High
CNÂ¥6.51
Low
CNÂ¥6.30
Mkt. cap
4.34B
Avg. vol.
10.14M
Volume
8.10M
52-wk high
CNÂ¥11.84
52-wk low
CNÂ¥5.90
EPS
-CNÂ¥2.16
Shares outstanding
661.28M
No. of employees
3K
Profile
Xiangxue Pharmaceutical Co., Ltd. also known as XPH, is a Chinese pharmaceutical company. It was headquartered in Guangzhou Economic and Technological Development Zone, Guangzhou, the capital of the Guangdong Province. The company started in a place that near to the tourist spot Luogang Xiangxue, thus called itself Xiangxue. Xiangxue Pharmaceutical was a constituent of SZSE 200 Index, but was removed in January 2017; it was inserted to SZSE 700 Index instead at the same time. SZSE 200, 300 and 700 Indexes are subsets of SZSE 1000 Index, the latter is a stock market index for the top 1,000 companies by free-float adjusted capitalization. In July 2017 Xiangxue was also removed from SZSE Component Index, an index for top 500 companies of the exchange. Wikipedia
About Xiangxue Pharmaceutical Co Ltd
CEO-
Employees2.66K
FoundedDec 29, 1997
Headquarters-
SectorPharmaceutical industry
Websitexphcn.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
327.92M
449.49M
354.16M
348.62M
Cost of goods sold
176.35M
388.48M
228.49M
246.72M
Cost of revenue
176.35M
388.48M
228.49M
246.72M
Research and development expenses
15.40M
22.13M
10.74M
11.51M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
132.20M
75.98M
89.74M
95.27M
Operating expense
153.13M
108.42M
97.82M
105.02M
Total operating expenses
329.48M
496.91M
326.31M
351.73M
Operating income
-1.56M
-47.41M
27.85M
-3.12M
Other non operating income
302.00K
-14.25M
-944.82K
-253.91M
EBT including unusual items
-118.29M
-1.00B
-89.20M
-147.88M
EBT excluding unusual items
-67.96M
-144.93M
-40.82M
-190.21M
Income tax expense
3.13M
30.08M
9.14M
5.48M
Effective tax rate
-2.65%
-3.00%
-10.25%
-3.70%
Other operating expenses
3.55M
4.05M
-3.18M
-1.26M
Net income
-128.03M
-1.03B
-111.44M
-157.38M
Net profit margin
-39.04%
-229.21%
-31.47%
-45.14%
Earnings per share
-
-
-
-
Interest and investment income
-
175.82K
23.18K
67.75M
Interest expense
-66.70M
-83.47M
-67.75M
-23.18K
Net interest expenses
-66.70M
-83.30M
-67.73M
67.73M
Depreciation and amortization charges
-
-
-
-
EBITDA
52.99M
15.22K
75.28M
49.47M
Gain or loss from assets sale
932.06K
-8.92M
-
-107.04K
AI content may include mistakes. Learn more
Google apps